Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CRACC/SLAMF7 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB19061100
This item is not returnable.
View return policy
Description
CRACC/SLAMF7 Monoclonal antibody specifically detects CRACC/SLAMF7 in Human samples. It is validated for ImmunohistochemistrySpecifications
CRACC/SLAMF7 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. | |
19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7, SLAMF7 | |
Mouse myeloma cell line NS0-derived recombinant human CRACC/SLAMF7, Lys27-Ser225, Accession # Q9NQ25 | |
100 μg | |
Primary | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 6 months, -20°C to -70°C under sterile conditions after reconstitution. | |
IgG2b |
Immunohistochemistry | |
235622 | |
Immunohistochemistry 5-25 ug/mL | |
Q9NQ25 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
57823 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction